Getein Biotech (SHSE:603387) Interest Expense : ¥-14 Mil (TTM As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Getein Biotech Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Getein Biotech's interest expense for the three months ended in Mar. 2024 was ¥ -3 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-14 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Getein Biotech's Operating Income for the three months ended in Mar. 2024 was ¥ 100 Mil. Getein Biotech's Interest Expense for the three months ended in Mar. 2024 was ¥ -3 Mil. Getein Biotech's Interest Coverage for the quarter that ended in Mar. 2024 was 34.42. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Getein Biotech Interest Expense Historical Data

The historical data trend for Getein Biotech's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Getein Biotech Interest Expense Chart

Getein Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-1.44

-6.22

-14.31

-16.61

-16.94

Getein Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-6.18	-3.18	-4.78	-2.80	-2.91

Getein Biotech Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-14 Mil.

Getein Biotech (SHSE:603387) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Getein Biotech's Interest Expense for the three months ended in Mar. 2024 was ¥-3 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥100 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ¥4 Mil.

Getein Biotech's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	100.265	/	-2.913
	=	34.42

The higher the ratio, the stronger the company's financial strength is.

Getein Biotech (SHSE:603387) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getein Biotech Inc (SHSE:603387) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 9 Bofu Road, Luhe District, Nanjing, CHN, 211505

Website

http://www.bio-gp.com.cn

Getein Biotech Inc is an in-vitro diagnostic company. It is specializing in analytical medical devices and point-of-care testing kits. Its product lines consist of cardiovascular, inflammatory, diabetes, fertility, renal, liver and specialty assays.

Executives

Su En Kui	Director
Yan Bin	Director
Kong Ting Ting	Director
Xu Xing De	Director
Su En Ben	Director

Getein Biotech (SHSE:603387) Headlines

No Headlines